{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:04:25Z","timestamp":1791047065313,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1378\/chest.126.2.375","type":"journal-article","created":{"date-parts":[[2004,8,9]],"date-time":"2004-08-09T21:58:38Z","timestamp":1092088718000},"page":"375-381","source":"Crossref","is-referenced-by-count":63,"title":["Characteristics of Airway Inflammation and Bronchodilator Reversibility in COPD"],"prefix":"10.1016","volume":"126","author":[{"given":"Diahn-Warng","family":"Perng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reury-Perng","family":"Perng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.2.375_bib1","series-title":"Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI\/WHO workshop report","author":"National Institutes of Health, National Heart, Lung, and Blood Institute","year":"2001"},{"key":"10.1378\/chest.126.2.375_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.2.375_bib3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1164\/ajrccm\/147.5.1126","article-title":"Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects","volume":"147","author":"Fahy","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib4","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1164\/ajrccm\/148.5.1226","article-title":"Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis","volume":"148","author":"Linden","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","article-title":"Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma","volume":"153","author":"Keatings","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thx.51.10.1000","article-title":"Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD","volume":"51","author":"Ronchi","year":"1996","journal-title":"Thorax"},{"key":"10.1378\/chest.126.2.375_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0091-6749(93)90078-T","article-title":"Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease","volume":"92","author":"Lacoste","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.126.2.375_bib8","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1164\/ajrccm.160.5.9810105","article-title":"Eosinophilic inflammation in stable chronic obstructive pulmonary disease: relationship with neutrophils and airway function","volume":"160","author":"Balzano","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.161.1.9802048","article-title":"The relationship between airways inflammation and asthma severity","volume":"161","author":"Louis","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","article-title":"Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma","volume":"145","author":"Djukanovic","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib11","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1056\/NEJM199906243402509","article-title":"Glucocorticoid therapy for chronic obstructive pulmonary disease","volume":"340","author":"Boushey","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.2.375_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.115.3.697","article-title":"Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema","volume":"115","author":"Fujimoto","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.375_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.126.2.375_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/arrd.1986.133.1.14","article-title":"Prognosis in chronic obstructive pulmonary disease","volume":"133","author":"Anthonisen","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib15","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1164\/ajrccm\/140.3_Pt_2.S100","article-title":"Prognosis of chronic obstructive pulmonary disease: the Dutch experience","volume":"140","author":"Postma","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib16","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","article-title":"Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease","volume":"162","author":"Papi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1164\/ajrccm\/138.2.317","article-title":"Clinical interpretation of airway response to a bronchodilator: epidemiologic considerations","volume":"138","author":"Dales","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1183\/09031936.93.06091249","article-title":"Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness","volume":"6","author":"Pin","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.2.375_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1034\/j.1399-3003.1999.13d24.x","article-title":"The cellular composition of induced sputum in chronic obstructive pulmonary disease","volume":"13","author":"Peleman","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.2.375_bib20","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1164\/rccm.2105025","article-title":"The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study","volume":"165","author":"Hattotuwa","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","article-title":"Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids","volume":"57","author":"Green","year":"2002","journal-title":"Thorax"},{"key":"10.1378\/chest.126.2.375_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1164\/ajrccm.155.5.9154853","article-title":"Corticosteroid reversibility in COPD is related to features of asthma","volume":"155","author":"Chanez","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thx.14.4.286","article-title":"Terminology, definitions and classification of chronic pulmonary emphysema and related conditions","volume":"14","author":"Ciba Foundation Guest Symposium","year":"1959","journal-title":"Thorax"},{"key":"10.1378\/chest.126.2.375_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thorax.58.8.654","article-title":"Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study","volume":"58","author":"Burge","year":"2003","journal-title":"Thorax"},{"key":"10.1378\/chest.126.2.375_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1378\/chest.126.2.375_bib26","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking: European Respiratory Society Study on Chronic Obstructive Pulmonary Disease","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.2.375_bib27","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200012283432601","article-title":"Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease","volume":"343","author":"Lung Health Study Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.2.375_bib28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/rmed.2001.1191","article-title":"Eosinophils in induced sputum from asymptomatic smokers with normal lung function","volume":"95","author":"Dippolito","year":"2001","journal-title":"Respir Med"},{"key":"10.1378\/chest.126.2.375_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.375_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/ajrccm\/146.3.555","article-title":"Acute bronchodilator trials in chronic obstructive pulmonary disease","volume":"146","author":"Nisar","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.375_bib31","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: Dutch Chronic Non-Specific Lung Disease Study Group","volume":"327","author":"Kerstjens","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.2.375_bib32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.123.5.1441","article-title":"Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses","volume":"123","author":"Tashkin","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.375_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/rmed.2003.1485","article-title":"Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation","volume":"97","author":"Sitkauskiene","year":"2003","journal-title":"Respir Med"},{"key":"10.1378\/chest.126.2.375_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.96.5.984","article-title":"Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison with that in normal subjects","volume":"96","author":"Gross","year":"1989","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T04:48:20Z","timestamp":1682743700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215311466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0012369215311466"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.2.375","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}